Research and development - Press Releases

Date	Title	Company
26-Oct-2022	Dante Genomics creates separate drug discovery and development company Genomic Biopharma Inc.	Dante Genomics
26-Oct-2022	CATALYZE DALLAS LAUNCHES ALMADEN GENOMICS, ENTERING RACE TO ADVANCE PACE OF GENOMIC RESEARCH	Catalyze Dallas Holdings
26-Oct-2022	ALMADEN GENOMICS ANNOUNCES LAUNCH OF G.NOME PLATFORM	Almaden Genomics
25-Oct-2022	Similis Bio Partners With Blau Farmaceutica to Co-Develop Four Biosimilar Programs	Similis Bio
25-Oct-2022	Tenon Medical’s Catamaran(TM) SI Joint Fusion System Receives Institutional Review Board Approval for Two Strategic Post Market Studies	Tenon Medical
25-Oct-2022	Intressa Vascular secures EUR 18 million in financing to support the development of its multilayer Allay™ Aortic Stent for the treatment of aortic dissection	Intressa Vascular
25-Oct-2022	Jean Boulle Group Receives US$47 million Cash Investment from a New Major Strategic Investor in its Proprietary VDYNE Technology - Set to Disrupt the Market for Heart Valve Replacement	Jean Boulle Group
25-Oct-2022	MYSTERY ABOUT THE EVOLUTION OF THE NERVOUS SYSTEM. MANY PROTEINS SHARE THE SAME FUNCTIONS.	Karl Landsteiner University
25-Oct-2022	OxSonics Presents Preclinical Data Demonstrating SonoTran® Enhanced the Delivery and Efficacy of an Oncolytic Virus in a Murine Bladder Cancel Model	OxSonics
25-Oct-2022	£4.34m Longitude Prize on Dementia launches innovator hackathons	Longitude Prize on Dementia
25-Oct-2022	Flavors into Over-the-Counter (OTC) Pharmaceuticals Market Trends Forecast And Industry Analysis To 2030	We Market Research
24-Oct-2022	Beckley Psytech strengthens pipeline and development team with acquisition of Eleusis Therapeutics Limited	Beckley Psytech
24-Oct-2022	Sartorius Enters Research Partnership with The BASE Facility at the University of Queensland	Sartorius
24-Oct-2022	PBD BIOTECH RAISES FURTHER £2.4M FOR ITS BREAKTHROUGH TUBERCULOSIS BLOOD TEST	PBD BIOTECH
24-Oct-2022	Cegedim acquires French medical data expert Clinityx, strengthening its position in Real-World-Data	Cegedim
24-Oct-2022	Study opens route to overcoming drug resistance in stomach cancer	The Institute of Cancer Research
22-Oct-2022	Tocopherol Mix Market Future Aspect Analysis And Current Trends By 2016 To 2030	We Market Research
19-Oct-2022	Creative Peptides Rolls Out Ready-to-Ship Fmoc-Tyr(HP03Bzl)-OH Product from Small Quantity to Large Scale	Creative Peptides
19-Oct-2022	AI-based Image Analysis for Bone Disease Diagnostics Assessed by Leading European University Clinic	ImageBiopsy Lab
19-Oct-2022	Rewind Therapeutics Appoints Irene Knuesel, PhD, as Chief Scientific Officer	Rewind Therapeutics